Cargando…
No durable impact of COVID-19 measures on the hospital burden of respiratory syncytial virus (France, 2018–2022)
Autores principales: | Fourgeaud, Jacques, Toubiana, Julie, Chappuy, Hélène, Delacourt, Christophe, Moulin, Florence, Parize, Perrine, Scemla, Anne, Abid, Hanene, Leruez-Ville, Marianne, Frange, Pierre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The British Infection Association. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9233884/ https://www.ncbi.nlm.nih.gov/pubmed/35760301 http://dx.doi.org/10.1016/j.jinf.2022.06.019 |
Ejemplares similares
-
Impact of public health measures on the post-COVID-19 respiratory syncytial virus epidemics in France
por: Fourgeaud, Jacques, et al.
Publicado: (2021) -
Preventing respiratory syncytial virus infections in hospitalized children and adults: should we do better?
por: Frange, Pierre, et al.
Publicado: (2020) -
Stewardship program on carbapenem prescriptions in a tertiary hospital for adults and children in France: a cohort study
por: Poline, Julie, et al.
Publicado: (2021) -
The shift in rabies epidemiology in France: time to adjust rabies post-exposure risk assessment
por: Parize, Perrine, et al.
Publicado: (2018) -
Distinctive Features of Kawasaki Disease Following SARS-CoV-2 Infection: a Controlled Study in Paris, France
por: Toubiana, Julie, et al.
Publicado: (2021)